Alum na UCF da masu bincike da yawa sun yi amfani da nanotechnology don haɓaka wannan wakili mai tsabta, wanda zai iya tsayayya da ƙwayoyin cuta guda bakwai har zuwa kwanaki 7.
Masu binciken UCF sun ƙera wani maganin kashe kwayoyin cuta na nanoparticle wanda zai iya ci gaba da kashe ƙwayoyin cuta a saman sama har zuwa kwanaki 7-binciken da zai iya zama makami mai ƙarfi akan COVID-19 da sauran ƙwayoyin cuta masu tasowa.
An buga binciken ne a wannan makon a cikin mujallar ACS Nano na American Chemical Society ta ƙungiyar ƙwararrun ƙwararrun ƙwayoyin cuta da ƙwararrun injiniya daga jami'a da kuma shugaban wani kamfanin fasaha a Orlando.
Christina Drake '07PhD, wacce ta kafa Kismet Technologies, ta sami wahayi ta hanyar tafiya zuwa kantin kayan miya a farkon cutar kuma ta haɓaka maganin kashe kwayoyin cuta. Can sai ta ga wata ma’aikaciya tana fesa maganin kashe kwayoyin cuta a hannun firij sai nan take ta goge feshin.
Dr. Greif Parks, masanin ilimin halittu a Makarantar Magunguna, ya haɓaka maganin kashe kwayoyin cuta tare da haɗin gwiwar injiniyoyi da 'yan kasuwa. Majiyar hoto: Jami'ar Central Florida
Ta ce, "Da farko ra'ayina shine in samar da maganin kashe kwayoyin cuta mai sauri," in ji ta, "amma mun yi magana da masu amfani da su kamar likitoci da likitocin hakora don fahimtar abin da suke so da gaske. Abu mafi mahimmanci a gare su shine abu ne mai ɗorewa, zai ci gaba da lalata manyan wuraren hulɗa kamar hannun kofa da bene na dogon lokaci bayan aikace-aikacen. "
Drake ya haɗu tare da Sudipta Seal, injiniyan kayan UCF kuma ƙwararren masanin ilimin kimiyyar nanoscience, da Griff Parks, masanin ilimin halittu, shugaban bincike na Makarantar Magunguna, kuma shugaban Burnett School of Biomedical Sciences. Tare da kudade daga Gidauniyar Kimiyya ta Kasa, Kismet Tech, da Babban Tech Corridor na Florida, masu bincike sun ƙirƙiri nanoparticle injin kashe ƙwayoyin cuta.
Abubuwan da ke aiki da shi shine injiniyan nanostructure da ake kira cerium oxide, wanda aka sani da kayan aikin antioxidant mai sabuntawa. Cerium oxide nanoparticles ana gyare-gyare tare da ƙaramin adadin azurfa don sa su fi tasiri a kan ƙwayoyin cuta.
Sudipta Seal injiniyan kayan aikin UCF ne kuma ƙwararren nanoscience wanda ke nazarin nanotechnology shekaru 20 da suka gabata. Majiyar hoto: Jami'ar Central Florida
"Yana aiki a duka biyun sunadarai da injiniyoyi," in ji Seal, wanda ya yi nazarin nanotechnology fiye da shekaru 20. “Nanoparticles suna fitar da electrons don yin oxidize da kwayar cutar kuma su sa ta zama mara aiki. A kan injina, suma suna jingina kansu da kwayar cutar kuma suna fasa saman, kamar fashe balan-balan."
Yawancin goge-goge ko feshi za su lalata saman cikin mintuna uku zuwa shida bayan amfani, amma babu sauran tasiri. Wannan yana nufin cewa saman yana buƙatar a maimaita akai-akai don kiyaye shi tsabta don guje wa kamuwa da ƙwayoyin cuta da yawa kamar COVID-19. Tsarin nanoparticle yana kiyaye ikonsa na hana ƙwayoyin cuta kuma yana ci gaba da lalata saman har zuwa kwanaki 7 bayan aikace-aikacen guda ɗaya.
Parks, wanda dakin gwaje-gwajensa ke da alhakin gwada juriyar tsarin kwayar cutar "kamus". "Ba wai kawai yana nuna kaddarorin antiviral akan coronaviruses da rhinoviruses ba, har ma yana tabbatar da cewa yana da tasiri a kan sauran ƙwayoyin cuta iri-iri tare da tsari daban-daban da rikitarwa. Muna fatan cewa tare da wannan ikon mai ban mamaki na kisa, wannan maganin zai kuma zama ingantaccen kayan aiki ga sauran ƙwayoyin cuta masu tasowa. "
Masana kimiyya sun yi imanin cewa wannan maganin zai yi tasiri sosai a kan yanayin kiwon lafiya, musamman ma rage yawan cututtukan da aka samu a asibiti, irin su Staphylococcus aureus mai maganin methicillin (MRSA), Pseudomonas aeruginosa da Clostridium difficile-- Suna shafar fiye da ɗaya a cikin 30. an kwantar da marasa lafiya a asibitocin Amurka.
Ba kamar yawancin magungunan kashe kwayoyin cuta na kasuwanci ba, wannan dabarar ba ta ƙunshi sinadarai masu cutarwa ba, wanda ke nuna cewa ba shi da haɗari a yi amfani da shi akan kowace ƙasa. Dangane da buƙatun Hukumar Kare Muhalli ta Amurka, gwaje-gwaje na tsari akan hanin fata da ƙwayoyin ido bai nuna wani illa mai cutarwa ba.
Drake ya ce "Da yawa daga cikin magungunan kashe kwayoyin cuta na gida a halin yanzu suna dauke da sinadarai masu cutarwa ga jiki bayan an maimaita bayyanar su." "Kayayyakinmu na tushen nanoparticle za su sami babban matakin aminci, wanda zai taka muhimmiyar rawa wajen rage yawan fallasa ɗan adam ga sinadarai."
Ana buƙatar ƙarin bincike kafin samfurori su shiga kasuwa, wanda shine dalilin da ya sa mataki na gaba na bincike zai mayar da hankali kan ayyukan ƙwayoyin cuta a aikace-aikace masu amfani a wajen dakin gwaje-gwaje. Wannan aikin zai yi nazarin yadda abubuwan da ke waje kamar zafin jiki ko hasken rana ke shafar abubuwan kashe ƙwayoyin cuta. Ƙungiyar tana tattaunawa tare da cibiyar sadarwa na asibiti don gwada samfurin a cikin wuraren su.
"Muna kuma binciken ci gaban fim na dindindin don ganin ko za mu iya rufewa da rufe benaye na asibiti ko hannayen ƙofa, wuraren da ke buƙatar lalata, ko ma wuraren da ke aiki da ci gaba da tuntuɓar," in ji Drake.
Magana: "Metal-metal-mediated nano-scale cerium oxide inactivates human coronavirus and rhinovirus through the surface destroys", Marubuta: Craig J. Neal, Candace R. Fox, Tamil Selvan Sakthivel, Udit Kumar, Yifei Fu, Christina Drake, Griffith D. Parks da Sudipta Seal, Agusta 26, 2021, ACS Nano.DOI: 10.1021/acsnano.1c04142
Seal ya shiga Sashen Kimiyya da Injiniya ta UCF a cikin 1997, wanda ke cikin Makarantar Injiniya da Kimiyyar Kwamfuta ta UCF. Prostheses. Shi ne tsohon darektan Cibiyar Kimiyya da Fasaha ta UCF Nano da Cibiyar Kula da Kayan Aiki da Ci gaba. Ya sami digiri na uku a fannin injiniyan kayan aiki daga Jami'ar Wisconsin, tare da ƙarami a fannin ilimin halittu, kuma mai bincike ne na gaba da digiri a Laboratory National Lawrence Berkeley a Jami'ar California, Berkeley.
Bayan ya yi aiki a Makarantar Magunguna ta Wake Forest na shekaru 20, Parkes ya zo UCF a cikin 2014, inda ya yi aiki a matsayin farfesa kuma shugaban Sashen Microbiology da Immunology. Ya samu Ph.D. a Biochemistry daga Jami'ar Wisconsin kuma mai bincike ne na Ƙungiyar Ciwon Kankara ta Amirka a Jami'ar Arewa maso Yamma.
Candace Fox, mai binciken digiri na biyu a Makarantar Magunguna, da Craig Neal daga Makarantar Injiniya da Kimiyyar Kwamfuta ne suka rubuta wannan binciken. Tamil Sakthivel, Udit Kumar, da Yifei Fu, daliban da suka kammala karatun digiri na Makarantar Injiniya da Kimiyyar Kwamfuta, su ma marubuta ne.
Ya kamata su yi amfani da azurfar colloidal kawai ba wasu shirme ba. Zai fi kyau a kan duk ƙwayoyin cuta masu cutarwa kuma baya buƙatar PhD ko miliyoyin hype da haƙƙin mallaka. kawai. Ba zai iya yin ba tare da haƙƙin mallaka ba.
Muna da wakili mai karewa wanda zai iya kiyaye daskararrun fiskoki har zuwa kwanaki 90 tare da kiyaye fiskoki masu laushi a shafe tsawon rayuwar samfurin. Ya wanzu shekaru da yawa. Mun kasance cikin kasuwanci tun 1978. Mu ba 'yan kayin Covid bane da suka bayyana a cikin Maris 2020. Don ƙarin bayani, tuntuɓi DSG Industrial Cleaning Systems a Kansas City, Missouri.
Colloidal azurfa yana aiki ta hanyar dakatar da sake zagayowar haifuwa. Babu juriya. Kamata ya yi a yi amfani da shi ko'ina. Ina ba da shawarar ta kuma dakatar da MERSA. Na yarda da duk wani abu da zai iya haɓaka azurfa. Wata yuwuwar ita ce allurar superabsorbent na matakin soja tare da dakatarwar barbashi na azurfa. Irin wannan abu yakamata yayi tasiri sosai.
SciTechDaily: Mafi kyawun gidan labarai na kimiyya da fasaha tun 1998. Ci gaba da sabuntawa tare da sabbin labaran fasaha ta imel ko kafofin watsa labarun.
Buƙatun ivermectin ya ƙaru. Ivermectin magani ne da ake amfani da shi sosai a cikin dawakai da shanu don magance tsutsotsi da sauran cututtuka masu saurin kamuwa da cuta a matsayin yiwuwar magani ko…
Lokacin aikawa: Satumba-10-2021